Skip to main content

Advertisement

SpringerLink
Log in

Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

We sought to determine the frequency of primary extranodal lymphoma (ENL) and its characteristics in Kanagawa, a human T-cell leukemia virus type 1 (HTLV-1) nonendemic area in Japan. Subjects were 847 newly diagnosed patients with malignant lymphoma at the Yokohama City University Hospital and 8 affiliated hospitals mainly located in Kanagawa prefecture from 1999 to 2005. We compared the clinicopathological characteristics of primary ENL with primary nodal lymphoma (NL). Histological specimens were evaluated according to the World Health Organization classifications. A total of 395 (46.6%) and 452 (53.4%) patients had primary ENL and primary NL, respectively. The frequency of primary ENL increased with age. Primary extranodal sites included the gastrointestinal tract (30.4%), Waldeyer’s ring (17.8%), orbits (7.0%), soft tissue and subcutaneous tissue (5.2%), bone (4.6%), skin (4.3%), thyroid gland (4.3%), testis and prostate (3.3%), bone marrow (3.3%), nasal and paranasal cavities (2.6%), salivary glands (2.3%), lung and pleura (2.0%), breast (1.8%), central nervous system (1.0%), uterus and ovary (0.5%), and others (9.8%). Among the 395 cases of primary ENL, diffuse large B-cell lymphoma (61.2%) was most frequently diagnosed, followed by extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (13.3%) and follicular lymphoma (5.6%). The frequency of primary ENL is approximately 50% of the total lymphoma cases in Kanagawa, an HTLV-1 nonendemic area in Japan. This frequency appears to be higher than that in Western countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res. 1971;31:1860–1.

    PubMed  CAS  Google Scholar 

  2. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001.

    Google Scholar 

  3. A predictive model for aggressive non-Hodgkin’s lymphoma: the International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987–94. doi:10.1056/NEJM199309303291402.

  4. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–60. doi:10.1002/1097-0142(197201)29:1≤252::AID-CNCR2820290138≥3.0.CO;2-#.

    Article  PubMed  CAS  Google Scholar 

  5. Sutcliff SB, Gospodarowicz MK. Clinical features and management of localized extranodal lymphomas. In: Keating A, Armitage J, Burnet A, Newland A, editors. Haematological oncology, vol 2. Cambridge: Cambridge University Press; 1992. p. 189–223.

  6. Ahmad M, Malik IA. Non-Hodgkin’s lymphoma in developing countries. In: Magrath IT, editor. The Non-Hodgkin’s lymphomas, 2nd ed. London: Arnold; 1997. p. 1031–54.

  7. d’Amore F, Christensen BE, Brincker H. Clinicopathological features and prognostic factors in extranodal non-Hodgkin’s lymphomas. Danish LYFO Study Group. Eur J Cancer. 1991;27:1201–8.

    Article  PubMed  CAS  Google Scholar 

  8. Otter R, Gerrits WB, Sandt MMVD, Hermans J, Willemze R. Primary extranodal and nodal non-Hodgkin’s lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol. 1989;25:1203–10. doi:10.1016/0277-5379(89)90416-1.

    Article  PubMed  CAS  Google Scholar 

  9. Takagi T. Clinical features of extranodal malignant lymphoma—staging classification and treatment strategies. Rinsho Ketsueki. 1999;40:188–91.

    PubMed  CAS  Google Scholar 

  10. Nitsu N, Okamoto M. Activities and analysis. In: Adult lymphoma treatment study group, editors. Malignant lymphoma clinical and pathology. Tokyo: Sentan-igakusha; 2005. p. 14–28.

  11. Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin’s lymphomas. Part 2: head and neck, central nervous system and other less common sites. Ann Oncol. 1999;10:1023–33. doi:10.1023/A:1008313229892.

    Article  PubMed  CAS  Google Scholar 

  12. Moller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation—a population-based study of 1575 cases. Br J Haematol. 2004;124:151–9. doi:10.1046/j.1365-2141.2003.04749.x.

    Article  PubMed  Google Scholar 

  13. Devesa SS, Fears T. Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res. 1992;52:5432s–40s.

    PubMed  CAS  Google Scholar 

  14. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000;92:1240–51. doi:10.1093/jnci/92.15.1240.

    Article  PubMed  CAS  Google Scholar 

  15. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin’s lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol. 1997;8:727–37. doi:10.1023/A:1008282818705.

    Article  PubMed  CAS  Google Scholar 

  16. Weisenburger DD. Epidemiology of non-Hodgkin’s lymphoma: recent findings regarding an emerging epidemic. Ann Oncol. 1994;5:19s–24s.

    Google Scholar 

  17. Levine PH, Hoover RN. The emerging epidemic of non-Hodgkin’s lymphoma: current knowledge regarding aetiologic factors. Cancer Res. 1992;52:5425s–574s.

    Google Scholar 

  18. Xu WS, Ho FC, Ho J, Chan AC, Srivastava G. Pathogenesis of gastric lymphoma: the enigma in Hong Kong. Ann Oncol. 1997;8:41–4. doi:10.1023/A:1008265829249.

    Article  PubMed  Google Scholar 

  19. Luppi M, et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol. 1996;94:373–5. doi:10.1046/j.1365-2141.1996.d01-1791.x.

    Article  PubMed  CAS  Google Scholar 

  20. López-Guillermo A, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol. 2005;23:2797–804. doi:10.1200/JCO.2005.07.155.

    Article  PubMed  Google Scholar 

  21. Bogomolski-Yahalom V, et al. Intravascular lymphomatosis—an indolent or aggressive entity? Leuk Lymphoma. 1998;29:585–93. doi:10.3109/10428199809050918.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We thank Dr. Juichi Tanabe for collecting clinical data from Fujieda Municipal General Hospital.

Author information

Authors and Affiliations

  1. Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan

    Atsuko Fujita, Naoto Tomita, Kenji Motohashi, Rie Hyo & Shin Fujisawa

  2. Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

    Naoto Tomita, Heiwa Kanamori & Yoshiaki Ishigatsubo

  3. Department of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan

    Hiroyuki Fujita

  4. Department of Hematology/Immunology, Fujisawa City Hospital, Kanagawa, Japan

    Etsuko Yamazaki

  5. Department of Internal Medicine, Yokohama Ekisaikai Hospital, Yokohama, Japan

    Michiko Hattori

  6. Department of Hematology, Yokosuka City Hospital, Kanagawa, Japan

    Koji Ogawa

  7. Department of Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan

    Shigeki Motomura & Fumio Kodama

Authors
  1. Atsuko Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoto Tomita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroyuki Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenji Motohashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rie Hyo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Etsuko Yamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michiko Hattori
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shin Fujisawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Heiwa Kanamori
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Koji Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shigeki Motomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Fumio Kodama
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yoshiaki Ishigatsubo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoto Tomita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujita, A., Tomita, N., Fujita, H. et al. Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan. Med Oncol 26, 49–54 (2009). https://doi.org/10.1007/s12032-008-9080-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-008-9080-0

Keywords

Search

Navigation